FDA cautions that Evusheld may not be effective against the XBB.1.5 omicron subvariant, new studies suggest the coronavirus may be able to survive in infected patients even after death, and more in this week's roundup of COVID-19 news.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
1 free members-only resources remaining this month
1 free members-only resources remaining this month
You've reached your limit of free monthly insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free monthly insights